In clinical treatment, Skullcapflavone I was confirmed to affect the cell proliferation of CRC cells by blocking MEK/ERK and NF-κB by regulating TPM1 and miR-107 [81]. This evidence concerns the gene TPM1 and colorectal carcinoma.